Literature DB >> 8767705

Molecular basis of Brucella pathogenicity: an update.

F J Sangari1, J Agüero.   

Abstract

Microorganisms belonging to the genus Brucella can infect humans and many species of animals. Virulence of the brucellae is thought to be essentially due to their capacity to survive and replicate within the phagocytic cells. However, many gaps remain in our understanding of this ability of brucellae to elude the bactericidal effects of host phagocytes, and basic questions remain unanswered. Identification of Brucella gene products which are related to intracellular survival, as well as those which contribute to the induction of protective immunity, is critical to elucidate the molecular mechanisms of the pathogenesis of the organism. The present article summarizes the current status of the research on gene products and other structural or metabolic factors associated with virulence of the brucellae.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8767705

Source DB:  PubMed          Journal:  Microbiologia        ISSN: 0213-4101


  18 in total

1.  Interleukin 10 suppresses lysosome-mediated killing of Brucella abortus in cultured macrophages.

Authors:  Huynh Tan Hop; Alisha Wehdnesday Bernardo Reyes; Tran Xuan Ngoc Huy; Lauren Togonon Arayan; WonGi Min; Hu Jang Lee; Man Hee Rhee; Hong Hee Chang; Suk Kim
Journal:  J Biol Chem       Date:  2018-01-04       Impact factor: 5.157

2.  Comparative study of the roles of AhpC and KatE as respiratory antioxidants in Brucella abortus 2308.

Authors:  Kendra H Steele; John E Baumgartner; Michelle Wright Valderas; R Martin Roop
Journal:  J Bacteriol       Date:  2010-07-30       Impact factor: 3.490

3.  Brucella abortus cyclic beta-1,2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in HeLa cells.

Authors:  G Briones; N Iñón de Iannino; M Roset; A Vigliocco; P S Paulo; R A Ugalde
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

4.  Induction of immune response in BALB/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella spp.

Authors:  A Al-Mariri; A Tibor; P Mertens; X De Bolle; P Michel; J Godfroid; K Walravens; J J Letesson
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

5.  Virulence criteria for Brucella abortus strains as determined by interferon regulatory factor 1-deficient mice.

Authors:  Jinkyung Ko; Annette Gendron-Fitzpatrick; Thomas A Ficht; Gary A Splitter
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

6.  Lipopolysaccharides of Brucella abortus and Brucella melitensis induce nitric oxide synthesis in rat peritoneal macrophages.

Authors:  L López-Urrutia; A Alonso; M L Nieto; Y Bayón; A Orduña; M Sánchez Crespo
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

7.  The Brucella suis homologue of the Agrobacterium tumefaciens chromosomal virulence operon chvE is essential for sugar utilization but not for survival in macrophages.

Authors:  M T Alvarez-Martinez; J Machold; C Weise; H Schmidt-Eisenlohr; C Baron; B Rouot
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

8.  Role of Toll-like receptor 4 in induction of cell-mediated immunity and resistance to Brucella abortus infection in mice.

Authors:  Marco A Campos; Gracia M S Rosinha; Igor C Almeida; Xirlene S Salgueiro; Bruce W Jarvis; Gary A Splitter; Nilofer Qureshi; Oscar Bruna-Romero; Ricardo T Gazzinelli; Sergio C Oliveira
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 9.  Survival of the fittest: how Brucella strains adapt to their intracellular niche in the host.

Authors:  R Martin Roop; Jennifer M Gaines; Eric S Anderson; Clayton C Caswell; Daniel W Martin
Journal:  Med Microbiol Immunol       Date:  2009-09-22       Impact factor: 3.402

10.  Toll-like receptor 4-linked Janus kinase 2 signaling contributes to internalization of Brucella abortus by macrophages.

Authors:  Jin Ju Lee; Dong Hyeok Kim; Dae Geun Kim; Hu Jang Lee; Wongi Min; Man Hee Rhee; Jae Youl Cho; Masahisa Watarai; Suk Kim
Journal:  Infect Immun       Date:  2013-04-29       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.